Disease News

FDA Approves Genzyme’s Oral Drug For Gaucher Disease

Monday, August 25th, 2014

Cerdelga (eliglustat) Capsules Approved for Adult Patients with Type 1 Gaucher Disease.

read more...

GDF Board Member Marion Yanovsky Honored by NTSAD

Nearly 50 Years of Service Recognized

read more...

Mount Sinai Expands Genetic Carrier Screening with New Sequencer

Monday, August 4th, 2014

Ashkenazi Jewish Screening Panel Now Covers 38 Rare Genetic Diseases

read more...

Mount Sinai and Genetic Disease Foundation Celebrate “Food For Life” Program

GDF Enlists internationally-recognized designer to enhance program area

read more...

Pfizer Gaucher Treatment Receives Kosher Certification

Tuesday, May 20th, 2014

First prescription medication to be certified kosher by the OU

read more...

Documentary Film “Undiagnosed: Medical Refugees” Seeks Funding

Friday, May 16th, 2014

Kickstarter Campaign Set to take Contributions Beginning at $1

read more...

Genzyme 2014 U.S. Scholarship Program Open for Submissions

Tuesday, May 13th, 2014

Chart Your Own Course Scholarships for Students with Lysosomal Storage Disorders

read more...

Genzyme Presents Safety Overview for Cerdelga™

Tuesday, March 18th, 2014

Preliminary Data Appear Promising for Potential Gaucher Oral Therapy

read more...

Shire Global Charitable Access Program Accepting Applications

Thursday, February 13th, 2014

For Patients with Gaucher, Fabry, MPS II (Hunter syndrome)

read more...

“Food for Life” Program Established at Mount Sinai Metabolic Clinic

GDF Supports Establishment of Innovative Initiative for Patients

read more...